Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
Condition(s):Knee Arthroplasty, TotalLast Updated:March 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Knee Arthroplasty, TotalLast Updated:March 12, 2024Recruiting
Condition(s):NAFLD – Nonalcoholic Fatty Liver DiseaseLast Updated:October 21, 2021Terminated
Condition(s):HealthyLast Updated:October 27, 2020Unknown status
Condition(s):COVID-19Last Updated:May 10, 2021Completed
Condition(s):Hypertension,NephropathyLast Updated:November 5, 2018Unknown status
Condition(s):Heart FailureLast Updated:November 2, 2018Withdrawn
Condition(s):Pulmonary Vein Stenosis; ChildrenLast Updated:July 30, 2019Suspended
Condition(s):Glomerulonephritis, IGALast Updated:October 10, 2018Completed
Condition(s):Breast Cancer; Myocardial Fibrosis; Radiation-Induced FibrosisLast Updated:January 12, 2024Recruiting
Condition(s):Sickle Cell DiseaseLast Updated:July 17, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.